Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty

Journal of Arthroplasty

Volumn 29, Issue 8, 2014, Pages 1512-1515

  Tuttle, John R ^a   Ritterman, Scott A ^a   Cassidy, Dale B ^a   Anazonwu, Walter A ^a   Froehlich, John A ^a   Rubin, Lee E ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Financial; Primary arthroplasty; Tranexamic acid; Transfusion

Indexed keywords

ACETYLSALICYLIC ACID; CEFAZOLIN; CLINDAMYCIN; HEMOGLOBIN D; TRANEXAMIC ACID; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEEP VEIN THROMBOSIS; DRUG COST; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPERATION DURATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; REOPERATION; RETROSPECTIVE STUDY; THROMBOSIS PREVENTION; TOPICAL TREATMENT; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; UNSPECIFIED SIDE EFFECT;

FINANCIAL; PRIMARY ARTHROPLASTY; TRANEXAMIC ACID; TRANSFUSION;

ADMINISTRATION, TOPICAL; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COST SAVINGS; COST-BENEFIT ANALYSIS; FEMALE; HEMOGLOBINS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84905122915     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2014.01.031     Document Type: Article

References (24)

1. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81:2.
2. Keating E.M., et al. Hemoglobin management in hip arthroplasty. Semin Arthroplasty 2000, 11:174.
3. Forbes J.M., et al. Blood transfusion costs: a multicenter study. Transfusion 1991, 31:318.
4. Alshryda S., Sarda P., Sukeik M., et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg (Br) 2011, 93-B:1577.
5. Wind T.C., Barfield W.R., Moskal J.T. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty 2014, 29:387.
6. Kagoma Y.K., Crowther M.A., Douketis J., et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009, 123:687. doi. 2008.
7. Kuroda R., Ishida K., Tsumura N., et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011, 35:1639.
8. Chimento G.F., Huff T., Ochsner J.L., et al. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplast 2013, 28:74.
9. Shander A., Hofmann A., Spahn D., et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010, 50:753.
10. Parvizi J., et al. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplast 2010, 25:103.
11. Mahomed N.N., Davis A.M., et al. Inpatient compared with home-based rehabilitation following primary unilateral total hip or knee replacement: a randomized controlled trial. J Bone Joint Surg 2008, 90-A(8):1673.
12. Wong J., Abrishami W., El Behiery H., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. J Bone Joint Surg Am 2010, 92:2503.
13. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet 2010, 376:23. CRASH-2 trial collaborators.
14. Etchason J., et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995, 332(11):719. 10.1056/NEJM199503163321106.
15. Sculco T.P., Gallina J. Blood management experience: relationship between autologous blood donation and transfusion in orthopedic surgery. Orthopedics 1999, 22(Suppl 1):s129.
16. Friederichs M.G., Mariani E.M., Bourne M.H. Perioperative blood salvage as an alternative to predonating blood for primary total knee and hip arthroplasty. J Arthroplasty 2002, 17:298.
17. Guerra J.J., Cuckler J.M., et al. Cost effectiveness of intraoperative autotransfusion in total hip arthroplasty surgery. Clin Orthop Relat Res 1995, 212.
18. Coyle D., et al. Economic analysis of erythropoietin use in orthopaedic surgery. Transfus Med 1999, 9(1):21. 10.1046/j.1365-3148.1999.009001021.x.
19. Sepah Y.J., et al. Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. J Orthop Surg Res 2011, 6:22.
20. Seo J.G., Moon Y.W., Park S.H., et al. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2013, 21:1869.
21. Konig G., Hamlin B.R., Waters J.H. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty 2013, 28:1473.
22. Gillette B.P., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013, 10.1016/j.arth.2013.04.054.
23. Georgiadis A.G., Muh S.J., Silverton C.D., et al. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplast 2013, 28:78.
24. Lee S.H., Cho K.-Y., Khurana S., et al. Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2013, 21:2611.